Internal Standard Capillary Electrophoresis as a High-Throughput Method for pKa Determination in Drug Discovery and Development

2014 ◽  
Vol 16 (10) ◽  
pp. 518-525 ◽  
Author(s):  
Joan M. Cabot ◽  
Elisabet Fuguet ◽  
Martí Rosés
2015 ◽  
Vol 87 (12) ◽  
pp. 6165-6172 ◽  
Author(s):  
Joan M. Cabot ◽  
Elisabet Fuguet ◽  
Martí Rosés ◽  
Petr Smejkal ◽  
Michael C. Breadmore

2011 ◽  
Vol 3 (11) ◽  
pp. 2557 ◽  
Author(s):  
Yun-Kai Lv ◽  
Yue-Na Sun ◽  
Li-Min Wang ◽  
Cui-Ling Jia ◽  
Han-Wen Sun

2002 ◽  
Vol 74 (16) ◽  
pp. 3963-3971 ◽  
Author(s):  
Gary R. Eldridge ◽  
Hélène C. Vervoort ◽  
Chris M. Lee ◽  
Peadar A. Cremin ◽  
Caroline T. Williams ◽  
...  

2020 ◽  
Vol 12 (10) ◽  
pp. 939-947 ◽  
Author(s):  
Nurken Berdigaliyev ◽  
Mohamad Aljofan

A new medicine will take an average of 10–15 years and more than US$2 billion before it can reach the pharmacy shelf. Traditionally, drug discovery relied on natural products as the main source of new drug entities, but was later shifted toward high-throughput synthesis and combinatorial chemistry-based development. New technologies such as ultra-high-throughput drug screening and artificial intelligence are being heavily employed to reduce the cost and the time of early drug discovery, but they remain relatively unchanged. However, are there other potentially faster and cheaper means of drug discovery? Is drug repurposing a viable alternative? In this review, we discuss the different means of drug discovery including their advantages and disadvantages.


Sign in / Sign up

Export Citation Format

Share Document